1124 results about "Common cold" patented technology

Frequent application of a virucidal hand lotion containing malic acid, citric acid, and a C1-6 alcohol will prevent the hand-to-hand transmission of rhinoviruses and reduce the incidence of the "common cold" caused by rhinoviruses.

The invention relates to a composition for killing virus and preventing influenza and a cold prevention plaster prepared by the composition. An aromatic traditional Chinese medicine volatile extract product and fragrant plant essential oil are used as effective components of the plaster; high-molecular colloid, which can be compatible with the effective components and has a stereo network structure, and an excipient are used to wrap the effective components to prepare a microcapsule; the microcapsule is used to coat on a matrix to prepare a tablet; a double faced adhesive tape is used to plaster the tablet at the position close to mouth and nose (such as collar, shoulder, chest and the like) so as to allow the effective components to slowly release at uniform speed. The plaster can be used to kill pathogen and virus in the air and enhance the immunity of upper respiratory tract, has an obvious effect of preventing influenza, and has a certain prevention effect for common cold, hand-foot-mouth disease, varicella, measles, epidemic encephalitis B, epidemic mumps, chronic respiratory tract diseases and the like. The plaster is convenient to use, has fragrant smell and is safe without side-effect.

The selenium-rich rice cultivating process includes conventional cultivation and features that the selenium-rich agent is sprayed once during the earing up and flowering period of rice. The selenium-rich agent comprising selenium-containing inorganic compound and phosphate is dissolved in water of 50-90 times and sprayed to leaf of rice during the earing up and flowering period of rice. In case of rainy day after spraying, replenished selenium-rich agent is sprayed timely. The sprayed inorganic selenium will be converted completely into natural organic selenium, and the produced selenium-rich rice is non-toxic, and has the health functions of preventing common cold, preventing and treating hypertension and myocardial pathological changes, etc.

The present invention relates to novel mixed release pharmaceutical formulations that include a expectorant available for immediate release and a decongestant for extended release that provide for the symptomatic relief of cough associated with respiratory tract conditions such as the common cold, bronchial asthma, acute and chronic bronchitis.

An agent for preventing / treating respiratory diseases contains, as an active ingredient, a compound represented by following Formula (I):wherein A is a group represented by L-W [wherein L is a bond or CH2; and W is O, SOn (wherein n is 0 to 2), or —NR7— (wherein R7 is hydrogen or lower alkyl)]; each of G1 and G2 is (CH2)r (wherein r is 0 to 2), provided that when n is 1, G1 and G2 may be bridged by lower alkylene; Y is a lower alkylene or (substituted) benzylidene; Z is a bond or O, provided that when Z is a bond, Y may form a 5- or 6-membered ring with carbon on the benzene ring; R1 is, for example, NO2, a lower alkoxycarbonyl, (substituted) carbamoyl, (protected) hydroxyl group, (protected) carboxyl, or (protected) N-hydroxycarbamoyl; each of R2 and R3 is hydrogen, halogen, (halogenated) lower alkyl, (halogenated) lower alkoxy or NO2; each of R4 and R5 is, for example, hydrogen, halogen, (halogenated) lower alkyl, (halogenated) lower alkoxy, CN, or lower alkylsulfonyl; and R6 is hydrogen or lower alkyl, a salt thereof or a solvate of them. It has excellent antitussive activity when used as an agent for preventing / treating respiratory diseases such as lung cancer, common cold syndrome, pulmonary tuberculosis, pneumonia, acute bronchitis or chronic bronchitis.

The invention provides a drug with effects of relieving cough and moistening lung. The drug is prepared from the following Chinese medicine materials: prepared rehmannia root, semen ginkgo, bulbus fritillariae cirrhosae, rhizoma polygonati, stigmata maydis, orange peel, folia eriobotryae, angelica decursiva, fructus aristolochiae, almond, semen lepidii, bamboo juice, honeysuckle, rice, medlar, stemona root, oroxylum indicum, liquorice, fructus schizandrae, rhizoma phragmitis, corn mint, figwort, lily, aster and rhizoma polygonati officinalis. The drug uses traditional Chinese herbal medicines as raw materials and is prepared through a scientific formulation and repeated validation of clinical test and meets the theory of traditional Chinese medicine; and the drug has the advantages of no toxicity, no side effect, short treatment course and high radical treatment efficiency. The drug can be used for treating common cold or cough, dry pharynx and other symptoms caused by acute and chronic bronchitis, and has the efficacies of replenishing qi, nourishing yin, moistening lung, relieving cough and the like; therefore, the drug has good social benefits when widely popularized.

Antiviral protease inhibitors, including peptidyl aldehydes, peptidyl α-ketoamides, peptidyl bisulfite salts, and peptidyl heterocycles, are disclosed, along with related antiviral compounds, and methods of using the same to treat or prevent viral infection and disease. The compounds possess broad-spectrum activity against viruses that belong to the picornavirus-like supercluster, which include important human and animal pathogens including noroviruses, enteroviruses, poliovirus, foot-and-mouth disease virus, hepatitis A virus, human rhinovirus (cause of common cold), human coronavirus (another cause of common cold), transmissible gastroenteritis virus, murine hepatitis virus, feline infectious peritonitis virus, and severe acute respiratory syndrome coronavirus.

The compositions of the present invention comprise a therapeutically effective amount of particles consisting of diphenhydramine or pharmaceutically acceptable salts thereof, optionally in combination with another drug such as pseudoephedrine, or phenylephrine and hydrocodone, in combination with rapidly-dispersing microgranules comprising a disintegrant and a sugar alcohol and / or a saccharide. These compositions are useful in treating the symptoms of one or more diseases or conditions in which diphenhydramine (alone or in combination with one or two other drugs) is a therapeutically effective, e.g. allergic rhinitis, sinusitis, upper respiratory tract infections, motion sickness, Parkinson's disease, insomnia, the common cold, and nighttime pain management, particularly for subjects or patients with dysphagia, and people ‘on the move’.

The invention discloses a dual-temperature-heat-pipe constant-temperature and constant-humidity air-conditioning unit, comprising an air treatment circulating system and a dual-temperature refrigeration circulating system which are coupled through a high-temperature evaporator (3) and a low-temperature evaporator (5), wherein the air treatment circulating system comprises an air inlet (1), a filter (2), the high-temperature evaporator (3), a heat pipe exchanger evaporation section (4), a low-temperature evaporator (5), an air blower (6), a heat pipe exchanger condensation section (7), an electric heater (8), an electrode-type steam humidifier (9) and an air supply outlet (10) which are arranged in sequence according to the air flowing path; and the dual-temperature refrigeration circulating system consists of a high-voltage level refrigeration circulating loop and a low-voltage level refrigeration circulating loop. The dual-temperature-heat-pipe constant-temperature and constant-humidity air-conditioning unit also comprises a temperature sensor (18), a temperature controller (20), a humidity sensor (19) and a humidity controller (21). The dual-temperature-heat-pipe constant-temperature and constant-humidity air-conditioning unit disclosed by the invention can be used for effectively solving the problem of the common cold-hot offset and has greater energy-saving potential.

Compositions and methods are presented that are useful for treatment of viral and / or bacterial infections, and especially the common cold or flu. Particularly preferred combinations include those orally administered, preferably early in the course of the symptoms of the cold or flu, and comprising (a) an H2-histamine receptor antagonist and (b) acetaminophen, NSAID, or other anti-pyretic, analgesic agent.

The invention discloses a serial Chinese medicinal preparation for treating child common cold, a preparation process and a quality control method thereof. Preparations are characterized by being prepared from traditional Chinese medicines, namely indigowoad leaf, Chinese thorowax root, baical skullcap root, fineleaf schizonepeta herb, platycodon root and liquoric root as well as pharmaceutical excipients. The preparations have the effects of clearing away heat, relieving exterior syndromes, reducing inflammation and relieving cough, and are used for common cold and fever, headache and stuffed-up nose, cough and sneeze, and sore throat. Volatile oil from Chinese thorowax root is a material base of the 'defervescence' of the preparation, has the characteristic of quick defervescence, and is an active ingredient for treating exogenous fever of children; and the traditional preparation process is to adopt a way of spraying the volatile oil into the preparation, and the volatile oil is almost completely lost during the production and storage due to the low content of the volatile oil, so that the clinical therapeutic effect is seriously affected. In the preparation process, a beta-cyclodextrin inclusion technology is adopted for the inclusion of the volatile oil from Chinese thorowax root to ensure that a liquid medicine is solidified; and thus the loss of the volatile oil during the production and storage is reduced, and the stability of the medicine is improved and the clinical therapeutic effect of the medicine is ensured at the same time. In addition, the more perfect quality control method is used for ensuring the quality; meanwhile, the clinical medication formulation is also enriched, so that the clinical medication demand can be better met.

New stable compositions comprising the combination of a topically active vasoconstrictor and a topically active anticholinergic drug are disclosed. Preferably, the composition comprises ipratropium or a salt thereof in combination with xylometazoline hydrochloride and a salt thereof. Upon topically administering such compositions to a nasal mucosa in individuals suffering from the common cold the symptoms of rhinorrhea are significantly reduced.

The Chinese medicine for curing common cold is made up by using 11 Chinese medicinal materials of lonicera flower, bupleumrum root, pueraria root, ephedra, scutellaria root and others according to a certain weight mixing ratio. Said Chinese medicine can be made into one of pharmaceutically-described oral dosage forms, specially made into an oral liquor preparation. Besides, said invention provides its preparation method.

Antiviral protease inhibitors, including macrocylic transition state inhibitors and peptidomimetics are disclosed, along with related antiviral compounds, and methods of using the same to treat or prevent viral infection and disease. The compounds possess broad-spectrum activity against viruses that belong to the picornavirus-like supercluster, which include important human and animal pathogens including noroviruses, sapoviruses, enteroviruses, poliovirus, foot-and-mouth disease virus, hepatitis A virus, human rhinovirus (cause of common cold), human coronavirus (another cause of common cold), transmissible gastroenteritis virus, murine hepatitis virus, feline infectious peritonitis virus, and severe acute respiratory syndrome coronavirus.

A chemical composition and method for treatment of the common cold, sinusitis and other conditions associated with nasal congestion is provided. The chemical composition is made of predetermined concentrations of thymol, alcohol, eucalyptol, menthol, methyl salicylate, a preservative, saline solution and a buffer. The method includes the step of administering the chemical composition of the invention via either intranasal instillation, oral inhalation or intermittent positive pressure breathing. Administration of the chemical composition via the method of the invention clears the nasal passages and alleviates the symptoms of the common cold, sinusitis, and related conditions.

The invention discloses a pharmaceutical composition for curing allergic rhinitis. The pharmaceutical composition is mainly prepared by extracting the following effective components of a dozen of medical materials including white peony root, astragalus root, white atractylodes rhizome, ledebouriella root, Chinese angelica, magnolia flower, schisandra fruit, grassleaved sweetflag rhizome, cicada slough, liquorice, asarum, dark plum, cocklebur fruit, and the like. The specific active components of the pharmaceutical composition have the effects of strengthening spleen and supplementing qi, warmly nourishing kidney-yang and stopping tears and have remarkable therapeutic effects of curing the rhinitis and various symptoms such as acute and chronic rhinitis, paranasal sinusitis, sicca and atrophic rhinitis, and the like caused by common cold and other reasons.

The invention discloses traditional Chinese medicine toothpaste adopting grape seed matrix abrasive and a preparation method of the traditional Chinese medicine toothpaste. The traditional Chinese medicine toothpaste is prepared from smashed grape seed, hydrogenated artemisia oil, bamboo vinegar, water lily amino acid viscose silk protein, lactoferrin, polyethylene glycol, sodium citrate, sodium soybean protein acid, sodium cyclohexylsulfamate, potassium dodecyl sulfate, forsythiaside, tea polyphenol, persimmon polysaccharide, glycyrrhetinic acid, sodium alginate, nano attapulgite, porous micromolecule high-energy water and deionized water. Forsythiaside traditional Chinese medicine extract has effects of resisting bacteria, diminishing inflammation, reducing fever and treating wind-heat type common cold; forsythiaside matched with porous micromolecule high-energy water is subjected to micro molecularization treatment, so that efficacy and stability of forsythiaside are improved; the grape seed matrix abrasive which is miniaturized and passivated is adopted, so that harmfulness of abrasion is reduced, abrasion effect is improved, and toothpaste cost is reduced.

The invention discloses an application of sichuan lovage rhizome oil by supercritical CO2 extraction method in pharmacy, which can be used for treating vascular nerve cephalalgia, cerebral thrombus, cerebrovascular angiosclerosis, coronary heart diseases, angina pectoris, hypertension, or asomnia, or common cold, or women's dysmenorrheal.

The invention discloses a siraitia grosvenorii ginger tea and its producing method, and the siraitia grosvenorii ginger tea is prepared from the following raw materials: by weight, 200-400 parts of siraitia grosvenorii, 100-150 parts of fresh ginger, 2-3 parts of folium apocyni veneti, 2-3 parts of salvia plebeia, 1-2 parts of plains coreopsis, 1-3 parts of mint leaf, 1-2 parts of angelica, 2-3 parts of orange peel, 1-2 henry clematis root, 2-3 parts of boenninghausenia albiflora, 2-4 parts of wild tea fruit and 10-15 parts of brown sugar. According to the siraitia grosvenorii ginger tea formula, the boenninghausenia albiflora having the effects of removing heat, cooling blood, diminishing inflammation and activating blood is added, the folium apocyni veneti has the effects of calming the liver, calming the nerve, clearing heat and promoting moisture, and the siraitia grosvenorii ginger tea is reasonable and coordinated in compatibility, enhances the effects of relieving exterior syndrome, dispelling cold, warming the middle warmer and preventing vomiting, can prevent and treat common cold due to wind-cold, stomach cold and other symptoms, is simple in process, and convenient to storage and eat.

The invention discloses a combination drug for the treatment of colds, coughs and acute and chronic bronchitis and a preparation method thereof. The combination drug includes twenty six medicines, which are ephedra vulgaris, ligusticum chuanxiong hort, angelica, stemona, white mustard seed, shizandra, liquorice, biond magnolia flower, dried orange peel, pinellia tuber, perilla fruit, balloon flower, ligusticum, peppermint, radix peucedani, common coltsfoot flower, pepper, epimedium, raidx astragali, Dangshen, dried ginger, herb of fortune eupatorium, common rush, mulberry root bark, radix bupleuri and asarum. The preparation method is as follows: volatile oil is extracted from radix bupleuri, pepper, peppermint, biond magnolia flower, ligusticum chuanxiong hort, angelica, radix peucedani, asarum and ligusticum by steam distillation, and the distillate is collected in another container; after distillation, the water solution, dregs and other ingredients are decocted for three times after being added with water, the decoction solution is mixed and filtered, the filtered solution is concentrated into clear plaster, ethyl alcohol is added until the amount of alcohol reaches 65 percent, and the mixture is mixed uniformly, frozen and filtered, the ethyl alcohol is recycled, the filtered solution is concentrated again, the ethyl alcohol is added until the amount of alcohol reaches 75 percent, and then the solution is mixed well, frozen and filtered, the ethyl alcohol is recycled until the filtered solution has no smell of alcohol, and the drug is obtained.

The present invention relates to a medicine for curing common cold and its preparation method. Said medicine is made up by using isatis root, taurine, sucrose and dextrin through a certain preparation process. Said invention provides two preparation processes, first preparation process includes the following steps: decocting isatis root in water, filtering, concentrating, adding ethyl alcohol, standing still and precipitating, taking out supernatant fluid, concentrating, adding sucrose and dextrin, mixing them, adding taurine, mixing them, garanulating, drying to obtain finished product; the second preparation process includes the following steps: mixing isatis root extract and dextrin, adding ethyl alcohol, stirring them, adding taurine and sucrose, mixing them, adding ethyl alcohol, stirring them, granulating and drying so as to obtain the invented finished product.

The invention relates to a Chinese medicinal preparation having functions of enhancing immunity, promoting digestion and improving sleep. The Chinese medicinal preparation is prepared from the following Chinese herb medicines: rhizoma polygonati, medlar, spiny data seed, Chinese yam, tuckahoe, Chinese date, hawthorn, endothelium corneum gigeriae galli, fructus cannabis, rhodiola root, rhizoma atractylodis macrocephalae, epimedium, ganoderma lucidum, tortoise-shell glue and the like. The Chinese medicinal preparation has functions of tonifying kidney and spleen, invigorating Qi and nourishing blood, promoting blood circulation to dispel blood stasis and harmonizing internal organs and is used for treating and relieving senility symptoms, such as tiredness and fatigue, inappetence, insomnia and amnesia, soreness of waist and knees, dizziness or lightheadedness, nycturia, osteoporosis and susceptibility to common colds, which are caused by the deficiency of liver and kidney and hypoimmunity, of middle-aged or old people. Furthermore, the Chinese medicinal preparation can restore the immunity of middle-aged or old people and effectively treat and prevent cardiovascular diseases. The Chinese medicinal preparation has health-care functions of immunoregulation and senility deferment, is safe, does not have side effects, and can be taken for a long time.

The present invention relates to use of certain antiviral fragrances for reduction of viruses, in particular vira causing common cold. In one embodiment, the invention relates to pharmaceutical compositions comprising an antiviral fragrance, preferably menthol. Said compositions preferably also comprise one or more flavonoids. The invention also relates to treatment of common cold using said compositions.

In an effort to control the production of illegal drugs such as methamphetamine, new statutes have placed restrictions on the sale of common cold remedies that contain pseudoephedrine and other precursors used in the production of these illegal drugs. Many common products, such as Sudafed® cold medicine, have been removed from store shelves and are now behind the counter at most pharmacies. These legal restrictions vary from state to state, but most restrict the amount of product that can be purchased by quantity and time. These legal restrictions also require creation of a customer log that often includes the customer's name, address, government-issued photo identification number and / or signature. Clearance of these restricted product sales and creation of the customer log are time consuming tasks that result in long lines during the winter season. The present invention is an automated process to speed up the authorization process and creation of the customer logs. The process can be applied to a single store or multiple stores. The invention also includes a clearance terminal especially adapted for this process.

The invention provides a Chinese traditional medical preparation for curing fever, headache and cough caused by cold and a production method thereof. The preparation is made of Chinese traditional medicines such as Mussaenda philippica, ivy tree bark skin, platycodon root, sweet wormwood herb, narrowleaf screwtree root and liquoric root and so on with scientific preparation by combining the Chinese traditional medicine theory with the modern mechanical theory. The production method is that the medical materials are processed through the modern medicine making technology such as extraction with water, settlement with alcohol and concentration, and then powder milling and so on to be made into gain preparation, troche and capsule preparation, etc. The medicine has the functions of clearing away heat and toxic material and dispelling wind and relieving cough. The medicine is used for curing the fever, the headache and the cough caused by the cold.

The invention discloses a pharmaceutical composition for treating dry larynx, hoarseness, acute and chronic pharyngitis, tonsillitis caused by common cold and its preparing process, wherein the composition is prepared mainly from baikal skullcap root, Chinese olive, root of ballon flower, bamboo shavings, sterculia seed, reddish orange, bitter orange, mulberry leaf, prepared nutgrass flatsedge rhizome, purple perilla seed, purple perilla, linaloe and menthol. The composition is prepared by charging pharmaceutically acceptable excipient directly or indirectly through conventional processes, and can be prepared into any of the clinically acceptable dose forms, such as capsules, pills, tablets, lozenges, granules, oral liquids or injections.

A method and composition for reducing the symptoms of the common cold and flu in a human subject in need thereof, comprising the administration of an effective amount of an aqueous composition having all components dispersed as a dry powder concentrate or dissolved in a decoction therein comprising Black pepper, Cinnamon, Cumin, Ginger, Rose hip, Saffron, and Turmeric with Maple Syrup as a sweetener.

The invention provides a honeysuckle flower distillate beverage. The honeysuckle flower distillate beverage is characterized by comprising honeysuckle flower, chrysanthemum, sweet tea and pure water. The honeysuckle flower distillate beverage disclosed by the invention has the double effects of the honeysuckle flower and the chrysanthemum, and has a good curative effect on the treatment of the diseases caused by wind-heat type common cold and hypertension. Meanwhile, the sweet tea is added, so that the effects of clearing heat and moistening lung, and expelling phlegm and arresting coughing are strengthened, and therefore, the honeysuckle flower distillate beverage is a healthcare food suitable for people of all ages. The invention also discloses a production method of the honeysuckle flower distillate beverage.